- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Sight Sciences, Inc.: Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare System for the Treatment of Meibomian Gland Disease ("MGD") Showing Cost Savings Over Existing Reimbursed Treatment Options | 2 | GlobeNewswire (USA) | ||
| 11.12. | Where Sight Sciences Stands With Analysts | 2 | Benzinga.com | ||
| 11.12. | Sight Sciences, Inc. - 8-K, Current Report | - | SEC Filings | ||
| SIGHT SCIENCES Aktie jetzt für 0€ handeln | |||||
| 22.11. | Hedge Fund and Insider Trading News: Ken Griffin, Bridgewater Associates, AQR Capital Management, Brookfield Asset Management, Sight Sciences Inc (SGHT), Royal Caribbean Cruises Ltd (RCL), and More | 7 | Insider Monkey | ||
| 07.11. | Sight Sciences, Inc.: Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations | 2 | GlobeNewswire (USA) | ||
| 07.11. | Sight Sciences, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | Sight Sciences, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.10. | Sight Sciences, Inc.: Sight Sciences to Report Third Quarter Financial Results on November 7, 2024 | 2 | GlobeNewswire (USA) | ||
| 15.10. | Sight Sciences: TearCare Treatment Enhances Visual Outcomes And Symptoms In Dry Eye Disease Trial | 1 | RTTNews | ||
| 14.10. | Sight Sciences, Inc.: Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial | 1 | GlobeNewswire (USA) | ||
| 04.10. | Lake Street bekräftigt Kaufempfehlung für Sight Sciences-Aktien aufgrund des Wachstumspotenzials | 1 | Investing.com Deutsch | ||
| 04.10. | Sight Sciences shares reiterate Buy rating from Lake Street on growth potential | 1 | Investing.com | ||
| 26.09. | Sight Sciences gains Medicare coverage for eye surgery tech | 1 | Investing.com | ||
| 26.09. | Sight Sciences erhält Medicare-Abdeckung für Augenoperationstechnologie | 1 | Investing.com Deutsch | ||
| 26.09. | Sight Sciences, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 20.08. | Sight Sciences, Inc.: Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 02.08. | Sight Sciences, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 01.08. | Sight Sciences GAAP EPS of -$0.25 beats by $0.04, revenue of $21.4M beats by $0.05M | 1 | Seeking Alpha | ||
| 01.08. | Sight Sciences, Inc.: Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance | 176 | GlobeNewswire (Europe) | MENLO PARK, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| 18.07. | Sight Sciences, Inc.: Sight Sciences to Report Second Quarter Financial Results on August 1, 2024 | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,376 | +0,62 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 7,015 | -0,78 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,085 | +2,15 % | Butterfly Network (NYSE:BFLY) Shares Down 6.3% - What's Next? | ||
| CARMAT | 1,022 | -3,04 % | CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt | Buy-back by CARMAT of 2 million shares from Airbus for a symbolic sum of 1 euro. The shares so bought-back will be allocated to the repayment of the Company's financial debt, via their... ► Artikel lesen | |
| GOODRX | 4,445 | -1,66 % | GoodRx Reports Third Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released... ► Artikel lesen | |
| JOINT CORP | 10,100 | +0,30 % | JOINT Corp - 8-K, Current Report | ||
| TALKSPACE | 3,040 | +1,33 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| MIMEDX | 9,140 | -1,40 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 83,46 | +2,85 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,870 | +0,80 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| BIOMERICA | 0,275 | +1,18 % | BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| ATRICURE | 30,420 | -0,30 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| PROPHASE LABS | 0,650 | +2,59 % | ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline | ||
| PROGYNY | 14,480 | -0,07 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| AMWELL | 7,555 | +1,96 % | Amwell CFO Mark Hirschhorn takes on expanded role as COO |
SIGHT SCIENCES INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,030 (+0,85 %) liegt der Kurs bei 3,540 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIGHT SCIENCES INC finden Sie auf Wallstreet Online.
